The global nootropics market market size is calculated at USD 21.33 billion in 2025 and is predicted to surpass around USD 73.11 billion by 2034, accelerating at a CAGR of 14.74% from 2025 to 2034. The North America nootropics market market size surpassed USD 7.95 billion in 2024 and is expanding at a CAGR of 14.77% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Nootropics Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Nootropics Market Revenue and Volume, by Form
8.1.1. Capsules/Tablets
8.1.1.1. Market Revenue and Volume Forecast
8.1.2. Powder
8.1.2.1. Market Revenue and Volume Forecast
8.1.3. Drinks
8.1.3.1. Market Revenue and Volume Forecast
9.1. Nootropics Market Revenue and Volume, by Distribution Channel
9.1.1. Offline
9.1.1.1. Market Revenue and Volume Forecast
9.1.2. Online
9.1.2.1. Market Revenue and Volume Forecast
10.1. North America
10.1.1. Market Revenue and Volume Forecast, by Form
10.1.2. Market Revenue and Volume Forecast, by Distribution Channel
10.1.3. U.S.
10.1.3.1. Market Revenue and Volume Forecast, by Form
10.1.3.2. Market Revenue and Volume Forecast, by Distribution Channel
10.1.4. Rest of North America
10.1.4.1. Market Revenue and Volume Forecast, by Form
10.1.4.2. Market Revenue and Volume Forecast, by Distribution Channel
10.2. Europe
10.2.1. Market Revenue and Volume Forecast, by Form
10.2.2. Market Revenue and Volume Forecast, by Distribution Channel
10.2.3. UK
10.2.3.1. Market Revenue and Volume Forecast, by Form
10.2.3.2. Market Revenue and Volume Forecast, by Distribution Channel
10.2.4. Germany
10.2.4.1. Market Revenue and Volume Forecast, by Form
10.2.4.2. Market Revenue and Volume Forecast, by Distribution Channel
10.2.5. France
10.2.5.1. Market Revenue and Volume Forecast, by Form
10.2.5.2. Market Revenue and Volume Forecast, by Distribution Channel
10.2.6. Rest of Europe
10.2.6.1. Market Revenue and Volume Forecast, by Form
10.2.6.2. Market Revenue and Volume Forecast, by Distribution Channel
10.3. APAC
10.3.1. Market Revenue and Volume Forecast, by Form
10.3.2. Market Revenue and Volume Forecast, by Distribution Channel
10.3.3. India
10.3.3.1. Market Revenue and Volume Forecast, by Form
10.3.3.2. Market Revenue and Volume Forecast, by Distribution Channel
10.3.4. China
10.3.4.1. Market Revenue and Volume Forecast, by Form
10.3.4.2. Market Revenue and Volume Forecast, by Distribution Channel
10.3.5. Japan
10.3.5.1. Market Revenue and Volume Forecast, by Form
10.3.5.2. Market Revenue and Volume Forecast, by Distribution Channel
10.3.6. Rest of APAC
10.3.6.1. Market Revenue and Volume Forecast, by Form
10.3.6.2. Market Revenue and Volume Forecast, by Distribution Channel
10.4. MEA
10.4.1. Market Revenue and Volume Forecast, by Form
10.4.2. Market Revenue and Volume Forecast, by Distribution Channel
10.4.3. GCC
10.4.3.1. Market Revenue and Volume Forecast, by Form
10.4.3.2. Market Revenue and Volume Forecast, by Distribution Channel
10.4.4. North Africa
10.4.4.1. Market Revenue and Volume Forecast, by Form
10.4.4.2. Market Revenue and Volume Forecast, by Distribution Channel
10.4.5. South Africa
10.4.5.1. Market Revenue and Volume Forecast, by Form
10.4.5.2. Market Revenue and Volume Forecast, by Distribution Channel
10.4.6. Rest of MEA
10.4.6.1. Market Revenue and Volume Forecast, by Form
10.4.6.2. Market Revenue and Volume Forecast, by Distribution Channel
10.5. Latin America
10.5.1. Market Revenue and Volume Forecast, by Form
10.5.2. Market Revenue and Volume Forecast, by Distribution Channel
10.5.3. Brazil
10.5.3.1. Market Revenue and Volume Forecast, by Form
10.5.3.2. Market Revenue and Volume Forecast, by Distribution Channel
10.5.4. Rest of LATAM
10.5.4.1. Market Revenue and Volume Forecast, by Form
10.5.4.2. Market Revenue and Volume Forecast, by Distribution Channel
11.1. Cerebral Success
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Onnit
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Neurohacker Collective
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Natural Stacks
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Mind Lab Pro
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Nootropics Depot
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. OptiMind
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. TruBrain
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Peak Nootropics
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. SmartX by CogniTune
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
13.1. About Us
13.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
Schedule a Meeting
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample